SPL UNCLASSIFIED SECTION Add-on to 1-3 oral anti-hyperglycemic agents (metformin, sulfonylurea, or SGLT-2 inhibitor) SURPASS-4 (NCT03730662) was a 104-week open-label trial (52-week primary endpoint) that randomized 2002 adult patients with type 2 diabetes mellitus with increased cardiovascular risk to subcutaneous MOUNJARO 5 mg, MOUNJARO 10 mg, MOUNJARO 15 mg once weekly, or insulin glargine 100 units/mL once daily (1:1:1:3 ratio) on a background of metformin (95%) and/or sulfonylureas (54%) and/or SGLT2 inhibitors (25%)
Known as exendin, the peptide was similar in structure and function to GLP-1but only when glucose is high (think: right after a meal)
The middle third of the front thigh works best
It is important to distinguish between true tachycardia a sustained heart rate exceeding 100 beats per minute at restand palpitations , which are the subjective awareness of one's heartbeat
For many individuals, starting with a multivitamin, protein support, and electrolytes is enough to build a strong nutritional foundation
If dosage adjustments still dont work, you may need to explore other alternatives
/assets/images/provider/photos/2802570.png)
